OXFORD, England--(BUSINESS WIRE)--Perspectum Diagnostics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MRCP+, the worlds most advanced ...

This study is comparing the 2 chemotherapy drugs capecitabine (Xeloda) and teysuno. This trial was done to find out if oxaliplatin and 5FU is useful for people with advanced biliary tract cancer who ...

This trial was looking at photodynamic therapy (PDT) for biliary tree cancer (bile duct cancer or gallbladder cancer). Bile duct cancers (cholangiocarcinoma) and gallbladder cancers are known together ...

Alagille syndrome is a rare pediatric genetic disorder that can affect the liver, heart, kidneys, blood vessels, skeleton and other tissues. One major characteristic of this condition is abnormalities ...

Irinotecan combined with infusional 5-fluorouracil and folinic acid (folfiri) in patients with metastatic gastric cancer resistant to cisplatin-containing chemotherapy No significant financial ...

High-dose conformal radiotherapy and concomitant 5-FU, followed by gemcitabine for non-metastatic unresectable pancreatic carcinoma: A phase II prospective study No significant financial relationships ...